Adverum Biotechnologies, Inc. (ADVM) NASDAQ

2.28

+0.13(+6.05%)

Updated at July 01 04:00PM

Currency In USD

Valuation

Market Cap92.38M
Enterprise Value123.43M
P/E Ratio-0.38
PEG Ratio0.04
Price/Sales Ratio-18.52
Price/Book Ratio1.83
Enterprise/Revenue-35.45
Enterprise/EBITDA-1.1

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin48.27
Operating Margin46.93

Management Effectiveness

Return On Assets-0.91
Return On Equity-1.23

Income Statement

Revenue1M
Revenue/Share-0.12
Gross Profit-2.65M
EBITDA-127.27M
Net Income-130.93M
Diluted EPS-6.62

Balance Sheet

Total Cash83.08M
Total Cash/Share3.97
Total Debt93.18M
Total Debt/Equity3.53
Current Ratio3.57
Book Value Per Share1.26

Price History

52-Week Change-66.93
52-Week High10.14
52-Week Low1.78
Moving Average 50 Days2.61
Moving Average 200 Days4.87

Statistics

Average Volume394,475
Shares Outstanding20.89M
% Held by Institutions73.02

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateMarch 21, 2024